[
    [
        {
            "time": "2020-06-02",
            "original_text": "Coronavirus latest: Tuesday, June 2",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "latest",
                    "June"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Coronavirus latest: Tuesday, June 2",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "These 2 charts show why record-high stock valuations shouldn’t worry investors",
            "features": {
                "keywords": [
                    "charts",
                    "record-high",
                    "valuations",
                    "investors"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "These 2 charts show why record-high stock valuations shouldn’t worry investors",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Lilly Begins Coronavirus Study to Evaluate Antibody Therapy",
            "features": {
                "keywords": [
                    "Lilly",
                    "Coronavirus",
                    "Study",
                    "Antibody",
                    "Therapy"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Lilly Begins Coronavirus Study to Evaluate Antibody Therapy",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Coronavirus Treatment Search Still on, Lilly, Gilead Give Updates",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Treatment",
                    "Search",
                    "Lilly",
                    "Gilead",
                    "Updates"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Coronavirus Treatment Search Still on, Lilly, Gilead Give Updates",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "AstraZeneca Ranked Most Inventive, Roche Most Innovative",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Ranked",
                    "Inventive",
                    "Roche",
                    "Innovative"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "AstraZeneca Ranked Most Inventive, Roche Most Innovative",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Morning Bell With Jim Cramer: Buy Regeneron",
            "features": {
                "keywords": [
                    "Morning",
                    "Bell",
                    "Jim",
                    "Cramer",
                    "Buy",
                    "Regeneron"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Morning Bell With Jim Cramer: Buy Regeneron",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "NextGen (NXGN) Earnings and Revenues Beat Estimates in Q4",
            "features": {
                "keywords": [
                    "NextGen",
                    "Earnings",
                    "Revenues",
                    "Beat",
                    "Estimates",
                    "Q4"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "NextGen (NXGN) Earnings and Revenues Beat Estimates in Q4",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive",
            "features": {
                "keywords": [
                    "Buy",
                    "Lilly",
                    "AbbVie",
                    "Merck",
                    "Stocks",
                    "J.P.",
                    "Morgan",
                    "Pfizer",
                    "Expensive"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Don’t Only Bet on Fast Vaccines, Root for Covid Treatments",
            "features": {
                "keywords": [
                    "Bet",
                    "Fast",
                    "Vaccines",
                    "Root",
                    "Covid",
                    "Treatments"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Don’t Only Bet on Fast Vaccines, Root for Covid Treatments",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-02",
            "original_text": "Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions",
            "features": {
                "keywords": [
                    "Gilead",
                    "next",
                    "step",
                    "coronavirus",
                    "inhaled",
                    "remdesivir",
                    "easier-to-use",
                    "versions"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]